US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SDEV $7.48 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Medline Inc. - Class A common stock (NQ:MDLN)

35.61 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medline Inc. - Class A common stock

< Previous 1 2 3 4 Next >
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)
NEW YORK, NY - June 19, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via TheNewswire.com
News headline image
MEDLINE is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - June 18, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via NewMediaWire
News headline image
MEDLINE is Being Investigated for Potential Securities Law Violations - Contact Kaplan Fox & Kilsheimer LLP
NEW YORK, NY - June 18, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via TheNewswire.com
Medline (NASDAQ:MDLN) Q1 Earnings: Revenue Beats, But Profits Slip on Tariff and Cost Pressures ↗
Via Chartmill
Medline Inc. (NASDAQ:MDLN) Reports Q4 Revenue Beat but EPS Miss Amid Margin Pressure ↗
Via Chartmill
News headline image
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations
NEW YORK, NY - June 17, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via TheNewswire.com
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN
From Pomerantz LLP
Via GlobeNewswire
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations
NEW YORK, NY - June 16, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via TheNewswire.com
News headline image
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations
NEW YORK, NY - June 15, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (“Medline” or the “Company”) (NASDAQ: MDLN). 
Via TheNewswire.com
News headline image
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Medline Industries, Inc. (MDLN) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Medline Industries, Inc. (MDLN) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Why Symbotic Stock Slumped 21% in May And Just Hit a 2026 Low ↗
Is something seriously wrong with the automation expert, or is this a market overreaction and an opportunity to buy? 
Via The Motley Fool
Topics Economy
News headline image
Medline Inc. announces closing of upsized secondary offering of Class A common stock
From Medline Inc.
Via GlobeNewswire
News headline image
Medline announces participation in upcoming investor conferences
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
From Medline Inc.
Via GlobeNewswire
News headline image
Monashee Scales Back Its Bet on Structure Therapeutics ↗
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Medline Inc. announces launch of secondary offering of Class A common stock
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Reports First Quarter 2026 Results
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Inc. announces pricing of secondary offering of class A common stock
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Inc. announces launch of secondary offering of Class A common stock
From Medline Inc.
Via GlobeNewswire
News headline image
Medline Reports Fourth Quarter and Full Year 2025 Results
From Medline Inc.
Via GlobeNewswire
News headline image
Medline announces participation in the Barclays 28th Annual Global Healthcare Conference
From Medline Inc.
Via GlobeNewswire
News headline image
Symbotic Could Be a Massive Breakout Stock in 2026 After a 150% Surge in 2025 ↗
Symbotic's big growth moves of 2025 should propel the company to new highs. 
Via The Motley Fool
< Previous 1 2 3 4 Next >